Request Deal Involvement

EQT Life Sciences and OrbiMed led a €54m Series B round in MinervaX.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Gorrissen Federspiel

legal advisors

Gorrissen Federspiel

or

Principals

MINERVAX

target

MINERVAX

EQT LIFE SCIENCES

bidder

EQT LIFE SCIENCES

ORBIMED ADVISORS LLC

bidder

ORBIMED ADVISORS LLC

NOVO HOLDINGS A/S

bidder

NOVO HOLDINGS A/S

PUREOS BIOVENTURES

bidder

PUREOS BIOVENTURES

SANOFI VENTURES

bidder

SANOFI VENTURES

TRILL IMPACT

bidder

TRILL IMPACT

ADJUVANT CAPITAL

bidder

ADJUVANT CAPITAL

WELLINGTON PARTNERS GMBH

bidder

WELLINGTON PARTNERS GMBH

INDUSTRIFONDEN

bidder

INDUSTRIFONDEN

SUNSTONE LIFE SCIENCE VENTURES

bidder

SUNSTONE LIFE SCIENCE VENTURES

LF INVESTMENTS SARL

bidder

LF INVESTMENTS SARL

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - EQT Life Sciences and OrbiMed led a €54m Series B round in MinervaX.